BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiu MH, Yang GG, Tan YL, Chen DC, Tan SP, Wang ZR, Yang FD, Okusaga O, Soares JC, Zhang XY. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology. Schizophr Res 2014;156:9-14. [PMID: 24766914 DOI: 10.1016/j.schres.2014.03.024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Rački V, Petrić D, Kučić N, Gržeta N, Jurdana K, Rončević-gržeta I. Cortical gray matter loss in schizophrenia: Could microglia be the culprit? Medical Hypotheses 2016;88:18-21. [DOI: 10.1016/j.mehy.2015.12.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Misiak B, Stańczykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review. Schizophr Res 2018;192:16-29. [PMID: 28416092 DOI: 10.1016/j.schres.2017.04.015] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 15.8] [Reference Citation Analysis]
3 Kim SW, Jhon M, Kim JM, Smesny S, Rice S, Berk M, Klier CM, McGorry PD, Schäfer MR, Amminger GP. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study. PLoS One 2016;11:e0151417. [PMID: 26963912 DOI: 10.1371/journal.pone.0151417] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
4 Tomasik J, Schwarz E, Lago SG, Rothermundt M, Leweke FM, van Beveren NJM, Guest PC, Rahmoune H, Steiner J, Bahn S. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain Behav Immun 2016;52:178-86. [PMID: 26541453 DOI: 10.1016/j.bbi.2015.10.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
5 Xiu MH, Tian L, Chen S, Tan YL, Chen DC, Chen J, Chen N, De Yang F, Licinio J, Kosten TR, Soares JC, Zhang XY. Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain, Behavior, and Immunity 2016;57:116-24. [DOI: 10.1016/j.bbi.2016.03.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
6 Momtazmanesh S, Zare-Shahabadi A, Rezaei N. Cytokine Alterations in Schizophrenia: An Updated Review. Front Psychiatry 2019;10:892. [PMID: 31908647 DOI: 10.3389/fpsyt.2019.00892] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 16.3] [Reference Citation Analysis]
7 Yan J, Chen Y, Ju P, Gao J, Zhang L, Li J, Wang K, Zhang J, Li C, Xia Q, Zhu C, Zhang X. Network Association of Biochemical and Inflammatory Abnormalities With Psychiatric Symptoms in First-Episode Schizophrenia Patients. Front Psychiatry 2022;13:834539. [PMID: 35273531 DOI: 10.3389/fpsyt.2022.834539] [Reference Citation Analysis]
8 Kozłowska E, Agier J, Wysokiński A, Łucka A, Sobierajska K, Brzezińska-błaszczyk E. The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia. Psychiatry Research 2019;272:540-50. [DOI: 10.1016/j.psychres.2018.12.138] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
9 Prestwood TR, Asgariroozbehani R, Wu S, Agarwal SM, Logan RW, Ballon JS, Hahn MK, Freyberg Z. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav Brain Res 2021;402:113101. [PMID: 33453341 DOI: 10.1016/j.bbr.2020.113101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rajasekaran A, Shivakumar V, Kalmady SV, Narayanaswamy JC, Subbana M, Venugopal D, Amaresha AC, Venkatasubramanian G, Debnath M. The impact of IL10 polymorphisms and sHLA-G levels on the risk of schizophrenia. Asian Journal of Psychiatry 2016;23:39-43. [DOI: 10.1016/j.ajp.2016.06.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Solmi M, Veronese N, Thapa N, Facchini S, Stubbs B, Fornaro M, Carvalho AF, Correll CU. Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia. CNS Spectr 2017;22:415-26. [PMID: 28181901 DOI: 10.1017/S1092852916000638] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 7.6] [Reference Citation Analysis]
12 Bavato F, Cathomas F, Klaus F, Gütter K, Barro C, Maceski A, Seifritz E, Kuhle J, Kaiser S, Quednow BB. Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum. J Psychiatr Res 2021;140:141-8. [PMID: 34116440 DOI: 10.1016/j.jpsychires.2021.05.072] [Reference Citation Analysis]
13 Fu G, Zhang W, Dai J, Liu J, Li F, Wu D, Xiao Y, Shah C, Sweeney JA, Wu M, Lui S. Increased Peripheral Interleukin 10 Relate to White Matter Integrity in Schizophrenia. Front Neurosci 2019;13:52. [PMID: 30792621 DOI: 10.3389/fnins.2019.00052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
14 Lee EE, Ancoli-Israel S, Eyler LT, Tu XM, Palmer BW, Irwin MR, Jeste DV. Sleep Disturbances and Inflammatory Biomarkers in Schizophrenia: Focus on Sex Differences. Am J Geriatr Psychiatry 2019;27:21-31. [PMID: 30442531 DOI: 10.1016/j.jagp.2018.09.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Pillinger T, Osimo EF, Brugger S, Mondelli V, McCutcheon RA, Howes OD. A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis. Schizophr Bull 2019;45:1120-33. [PMID: 30407606 DOI: 10.1093/schbul/sby160] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 22.0] [Reference Citation Analysis]
16 Haring L, Koido K, Vasar V, Leping V, Zilmer K, Zilmer M, Vasar E. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index. Schizophrenia Research 2015;169:22-9. [DOI: 10.1016/j.schres.2015.08.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
17 Rodrigues-Amorim D, Rivera-Baltanás T, Spuch C, Caruncho HJ, González-Fernandez Á, Olivares JM, Agís-Balboa RC. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophr Res 2018;197:19-33. [PMID: 29239785 DOI: 10.1016/j.schres.2017.11.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
18 Kowalchuk C, Kanagasundaram P, Belsham DD, Hahn MK. Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons. Psychoneuroendocrinology 2019;104:42-8. [PMID: 30802709 DOI: 10.1016/j.psyneuen.2019.01.029] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
19 Goldsmith DR, Haroon E, Miller AH, Strauss GP, Buckley PF, Miller BJ. TNF-α and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res 2018;199:281-4. [PMID: 29499967 DOI: 10.1016/j.schres.2018.02.048] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
20 Pillai A, Howell KR, Ahmed AO, Weinberg D, Allen KM, Bruggemann J, Lenroot R, Liu D, Galletly C, Weickert CS, Weickert TW. Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. Mol Psychiatry 2016;21:686-92. [PMID: 26169975 DOI: 10.1038/mp.2015.96] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
21 Boozalis T, Teixeira AL, Cho RY, Okusaga O. C-Reactive Protein Correlates with Negative Symptoms in Patients with Schizophrenia. Front Public Health 2017;5:360. [PMID: 29404313 DOI: 10.3389/fpubh.2017.00360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
22 Kapelski P, Skibinska M, Maciukiewicz M, Pawlak J, Zaremba D, Twarowska-Hauser J. Family-based association study of interleukin 10 (IL10) and interleukin 10 receptor alpha (IL10RA) functional polymorphisms in schizophrenia in Polish population. J Neuroimmunol 2016;297:92-7. [PMID: 27397081 DOI: 10.1016/j.jneuroim.2016.05.010] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Roomruangwong C, Noto C, Kanchanatawan B, Anderson G, Kubera M, Carvalho AF, Maes M. The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia. Mol Neurobiol. 2019;. [PMID: 31473906 DOI: 10.1007/s12035-019-01737-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
24 Corsi-Zuelli F, Fachim HA, Loureiro CM, Shuhama R, Bertozi G, Joca SRL, Menezes PR, Louzada-Junior P, Del-Ben CM. Prolonged Periods of Social Isolation From Weaning Reduce the Anti-inflammatory Cytokine IL-10 in Blood and Brain. Front Neurosci 2018;12:1011. [PMID: 30686977 DOI: 10.3389/fnins.2018.01011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zhu F, Zhang L, Liu F, Wu R, Guo W, Ou J, Zhang X, Zhao J. Altered Serum Tumor Necrosis Factor and Interleukin-1β in First-Episode Drug-Naive and Chronic Schizophrenia. Front Neurosci 2018;12:296. [PMID: 29867314 DOI: 10.3389/fnins.2018.00296] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
26 Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain Behav Immun 2019;76:268-74. [PMID: 30496778 DOI: 10.1016/j.bbi.2018.11.315] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
27 Brown JS Jr. Cancer Immune Equilibrium and Schizophrenia Have Similar Interferon-γ, Tumor Necrosis Factor-α, and Interleukin Expression: A Tumor Model of Schizophrenia. Schizophr Bull 2016;42:1407-17. [PMID: 27169466 DOI: 10.1093/schbul/sbw064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016;21:1696-709. [PMID: 26903267 DOI: 10.1038/mp.2016.3] [Cited by in Crossref: 808] [Cited by in F6Publishing: 693] [Article Influence: 134.7] [Reference Citation Analysis]
29 Kartalci S, Karabulut AB, Erbay LG, Acar C. Effects of Electroconvulsive Therapy on Some Inflammatory Factors in Patients With Treatment-Resistant Schizophrenia. J ECT 2016;32:174-9. [PMID: 26886746 DOI: 10.1097/YCT.0000000000000303] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
30 Pan S, Tan Y, Yao S, Zhao X, Xiong J. Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia. Psychiatry Res 2016;246:89-94. [PMID: 27669496 DOI: 10.1016/j.psychres.2016.09.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
31 Supp AD, Avila S Jr, Mastella GA, Damásio L, de Oliveira IH, Godoi AK, Michels A, Schuck PF, Zugno AI. Ascorbic acid supplementation attenuates schizophrenia-like symptoms in an animal model induced by ketamine. Int J Dev Neurosci 2021;81:26-36. [PMID: 32780510 DOI: 10.1002/jdn.10058] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Liu L, Li Y, Bian Y, Yang F, Li X, Han X, Tian L, Chen S, Wang Z, Tan Y. Serum levels of oxidants and protein S100B were associated in the first-episode drug naïve patients with schizophrenia. Glob Clin Transl Res. [DOI: 10.36316/gcatr.01.0013] [Reference Citation Analysis]
33 Perry BI, Singh S. First-episode psychosis and abnormal glycaemic control – Authors' reply. The Lancet Psychiatry 2017;4:24. [DOI: 10.1016/s2215-0366(16)30411-4] [Reference Citation Analysis]
34 Kovács MÁ, Tényi T, Kugyelka R, Prenek L, Hau L, Magyar ÉE, Herold R, Balogh P, Simon D. Elevated Osteopontin and Interferon Gamma Serum Levels and Increased Neutrophil-to-Lymphocyte Ratio Are Associated With the Severity of Symptoms in Schizophrenia. Front Psychiatry 2019;10:996. [PMID: 32038330 DOI: 10.3389/fpsyt.2019.00996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Arabska J, Wysokiński A, Brzezińska-błaszczyk E, Kozłowska E. Serum Levels and in vitro CX3CL1 (Fractalkine), CXCL8, and IL-10 Synthesis in Phytohemaglutinin-Stimulated and Non-stimulated Peripheral Blood Mononuclear Cells in Subjects With Schizophrenia. Front Psychiatry 2022;13:845136. [DOI: 10.3389/fpsyt.2022.845136] [Reference Citation Analysis]
36 Kajitani K, Yanagimoto K, Nakabeppu Y. Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation. Psychopharmacology (Berl) 2017;234:2919-27. [PMID: 28698921 DOI: 10.1007/s00213-017-4683-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
37 Zhang Q, Hong W, Li H, Peng F, Wang F, Li N, Xiang H, Zhang Z, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Cai W, Fang Y, Xie B, Zhao M. Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression. Int J Psychophysiol 2017;114:9-15. [PMID: 28174109 DOI: 10.1016/j.ijpsycho.2017.02.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
38 Pillinger T, D'Ambrosio E, McCutcheon R, Howes OD. Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models. Mol Psychiatry 2019;24:776-94. [PMID: 29743584 DOI: 10.1038/s41380-018-0058-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 15.8] [Reference Citation Analysis]
39 Kozłowska E, Żelechowska P, Wysokiński A, Rasmus P, Łucka A, Brzezińska-Błaszczyk E. In vitro cytokine synthesis in unstimulated and mitogen-stimulated peripheral blood mononuclear cells from individuals with schizophrenia. J Investig Med 2019;67:1053-60. [PMID: 31053623 DOI: 10.1136/jim-2018-000964] [Reference Citation Analysis]
40 Sperner-unterweger B, Fuchs D. Schizophrenia and psychoneuroimmunology: an integrative view. Current Opinion in Psychiatry 2015;28:201-6. [DOI: 10.1097/yco.0000000000000153] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.4] [Reference Citation Analysis]
41 Borovcanin MM, Minic Janicijevic S, Jovanovic IP, Gajovic NM, Jurisevic MM, Arsenijevic NN. Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia. Diagnostics (Basel) 2020;10:E926. [PMID: 33182582 DOI: 10.3390/diagnostics10110926] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 You MJ, Bang M, Park HS, Yang B, Jang KB, Yoo J, Hwang DY, Kim M, Kim B, Lee SH, Kwon MS. Human umbilical cord-derived mesenchymal stem cells alleviate schizophrenia-relevant behaviors in amphetamine-sensitized mice by inhibiting neuroinflammation. Transl Psychiatry. 2020;10:123. [PMID: 32341334 DOI: 10.1038/s41398-020-0802-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
43 Chenniappan R, Nandeesha H, Kattimani S, Nanjaiah ND. Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia. Ann Neurosci 2020;27:24-8. [PMID: 32982096 DOI: 10.1177/0972753120929565] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Goldsmith DR, Rapaport MH. Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits. Front Psychiatry 2020;11:46. [PMID: 32153436 DOI: 10.3389/fpsyt.2020.00046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
46 Petrikis P, Voulgari PV, Tzallas AT, Archimandriti DT, Skapinakis P, Mavreas V. Cytokine profile in drug-naïve, first episode patients with psychosis. Journal of Psychosomatic Research 2015;79:324-7. [DOI: 10.1016/j.jpsychores.2015.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
47 Fourrier C, Singhal G, Baune BT. Neuroinflammation and cognition across psychiatric conditions. CNS Spectr 2019;24:4-15. [PMID: 30714555 DOI: 10.1017/S1092852918001499] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
48 Dunne PW, Roberts DL, Quinones MP, Velligan DI, Paredes M, Walss-Bass C. Immune markers of social cognitive bias in schizophrenia. Psychiatry Res 2017;251:319-24. [PMID: 28237910 DOI: 10.1016/j.psychres.2017.02.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
49 Hong W, Zhao M, Li H, Peng F, Wang F, Li N, Xiang H, Su Y, Huang Y, Zhang S, Zhao G, Zhou R, Mao L, Lin Z, Fang Y, Zhang Q, Xie B. Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers. Sci Rep 2016;6:27584. [PMID: 27279465 DOI: 10.1038/srep27584] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]